← CONMED Corp CNMD
Market Price
$50.46
Market Cap
$1.50B
P/E Ratio
33.42
Revenue (FY 2025)
↑5.2% YoY
$1.37B
3-Yr CAGR: 9.6%
Net Income
↓-64.5% YoY
$47.05M
Net Margin: 3.4%
Free Cash Flow
↓-2.0% YoY
$150.88M
FCF Yield: 10.06%
EPS (Diluted)
↓-64.5% YoY
$1.51
Basic: $1.52
Return on Equity
Efficiency
4.6%
ROA: 164.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (CNMD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $763.5M | — | $408.3M | $14.7M | — | $0.52 | — | $38.2M | $23.5M | — |
| FY 2017 | $796.4M | +4.3% | $431.0M | $55.5M | +278.4% | $1.97 | +278.8% | $65.6M | $52.7M | +124.7% |
| FY 2018 | $859.6M | +7.9% | $469.1M | $40.9M | -26.4% | $1.41 | -28.4% | $74.7M | $58.2M | +10.4% |
| FY 2019 | $955.1M | +11.1% | $524.7M | $28.6M | -29.9% | $0.97 | -31.2% | $95.1M | $75.1M | +29.0% |
| FY 2020 | $862.5M | -9.7% | $460.3M | $9.5M | -66.7% | $0.32 | -67.0% | $64.5M | $51.5M | -31.4% |
| FY 2021 | $1,010.6M | +17.2% | $568.0M | $62.5M | +557.2% | $1.94 | +506.2% | $111.8M | $96.9M | +88.1% |
| FY 2022 | $1,045.5M | +3.4% | $571.2M | $-80.6M | -228.8% | $-2.68 | -238.1% | $33.4M | $11.6M | -88.1% |
| FY 2023 | $1,244.7M | +19.1% | $676.2M | $64.5M | +180.0% | $2.04 | +176.1% | $125.3M | $106.3M | +818.1% |
| FY 2024 | $1,307.0M | +5.0% | $733.0M | $132.4M | +105.4% | $4.25 | +108.3% | $167.0M | $153.9M | +44.7% |
| FY 2025 | $1,374.7M | +5.2% | $750.5M | $47.1M | -64.5% | $1.51 | -64.5% | $170.7M | $150.9M | -2.0% |
Valuation
Market Price
$50.46
Market Cap
$1.50B
Enterprise Value
$2.31B
P/E Ratio
33.42
P/B Ratio
1.47
FCF Yield
10.06%
Dividend Yield
1.19%
Shares Outstanding
Profitability & Margins
Gross Margin
54.59%
Operating Margin
7.46%
Net Margin
3.42%
Return on Equity (ROE)
4.55%
Return on Assets (ROA)
164.13%
Asset Turnover
47.95x
Revenue 3-Yr CAGR
9.56%
Financial Health & Liquidity
Current Ratio
0.09
Cash Ratio
0.08
Debt / Equity
0.808
Debt / Assets
29.124
Cash & Equivalents
$25.86M
Total Debt
$834.94M
Book Value / Share
$34.31
Cash Flow Efficiency
Operating Cash Flow
$170.69M
Capital Expenditures (CapEx)
$19.81M
Free Cash Flow
$150.88M
OCF / Revenue
12.42%
FCF / Revenue
10.98%
FCF 3-Yr CAGR
135.31%
Per Share Metrics
EPS (Diluted)
$1.51
EPS (Basic)
$1.52
Dividends / Share
$0.60
Book Value / Share
$34.31
EPS YoY Growth
-64.47%
Balance Sheet (FY 2025)
Total Assets
$28.67M
Total Liabilities
$315.04M
Stockholders' Equity
$1.03B
Current Assets
$28.67M
Current Liabilities
$315.04M